1. Home
  2. CCEL vs ENLV Comparison

CCEL vs ENLV Comparison

Compare CCEL & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$3.45

Market Cap

32.7M

Sector

Health Care

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.00

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
ENLV
Founded
1989
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
26.6M
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
CCEL
ENLV
Price
$3.45
$1.00
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
15.3K
461.1K
Earning Date
02-27-2026
03-30-2026
Dividend Yield
11.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,747,500.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$0.66
52 Week High
$8.79
$2.10

Technical Indicators

Market Signals
Indicator
CCEL
ENLV
Relative Strength Index (RSI) 42.03 60.83
Support Level $3.35 $0.85
Resistance Level $3.50 $1.03
Average True Range (ATR) 0.25 0.07
MACD 0.01 0.03
Stochastic Oscillator 33.48 91.89

Price Performance

Historical Comparison
CCEL
ENLV

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: